Elesclomol (STA-4783)
≥98%
- Product Code: 77590
CAS:
488832-69-5
| Molecular Weight: | 400.52 g./mol | Molecular Formula: | C₁₉H₂₀N₄O₂S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Elesclomol is primarily investigated for its potential in cancer treatment, particularly in targeting oxidative stress mechanisms in cancer cells. It works by inducing oxidative stress, leading to cell death in malignant cells, which are often more susceptible to oxidative damage than normal cells. This property makes it a candidate for use in combination with other chemotherapeutic agents to enhance their efficacy. Clinical trials have explored its application in treating various cancers, including melanoma, where it has shown promise in improving progression-free survival when used alongside traditional therapies. Research continues to evaluate its effectiveness and safety in broader oncological applications.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Yellow Powder,Crystals or Solid |
| PURITY | 98-100 |
| MASS SPECTRUM | Conforms to standard |
| Infrared spectrum | Conforms to Structure |
| NMR | Consistent with structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿7,740.00 |
+
-
|
| 0.025 | 10-20 days | ฿26,810.00 |
+
-
|
| 0.100 | 10-20 days | ฿69,990.00 |
+
-
|
Elesclomol (STA-4783)
Elesclomol is primarily investigated for its potential in cancer treatment, particularly in targeting oxidative stress mechanisms in cancer cells. It works by inducing oxidative stress, leading to cell death in malignant cells, which are often more susceptible to oxidative damage than normal cells. This property makes it a candidate for use in combination with other chemotherapeutic agents to enhance their efficacy. Clinical trials have explored its application in treating various cancers, including melanoma, where it has shown promise in improving progression-free survival when used alongside traditional therapies. Research continues to evaluate its effectiveness and safety in broader oncological applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :